Bafna Pharmaceuticals Ltd

NSE: BAFNAPH · BSE: 532989 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹401.85
Market cap: ₹950.6 Cr
Revenue (annual): ₹150.6 Cr
Net profit (annual): ₹11.10 Cr
P/E (TTM): 122.1×Sector 47.4×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 9.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Board Meeting Date 2 Annual General Meeting 2 Price Movement Clarification 1 Other Announcement 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

11 Aug 2026 17:51 IST BSE

Financial Results

Bafna Pharmaceuticals Q1 FY27 Results: Net Profit ₹0.1 Cr, Down 97.1% YoY

Bafna Pharmaceuticals Ltd reported revenue from operations of ₹26.6 Cr (-23.1% YoY) and net profit of ₹0.1 Cr (-97.1% YoY) for Q1 FY27.

Key figure: Net profit ₹0.1 Cr · -97.1% YoY

Open full results → Read the filing ↗

29 May 2026 18:32 IST NSE

Financial Results

Bafna Pharmaceuticals Q4 FY26 Results: Net Profit ₹2.7 Cr, Up 107.7% YoY

Bafna Pharmaceuticals Ltd reported revenue from operations of ₹42.2 Cr (+7.9% YoY) and net profit of ₹2.7 Cr (+107.7% YoY) for Q4 FY26.

Key figure: Net profit ₹2.7 Cr · +107.7% YoY

Open full results → Read the filing ↗

29 May 2026 18:31 IST NSE

Financial Results

Bafna Pharmaceuticals Financial Results

Bafna Pharmaceuticals reported audited financial results for the year ended March 31, 2026. The filing includes the Balance Sheet, Cash Flow, and an unmodified auditor's report.

Read the filing ↗